Professional Advisory Services Inc. reduced its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 28.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,000 shares of the technology company’s stock after selling 400 shares during the quarter. Professional Advisory Services Inc.’s holdings in Veeva Systems were worth $210,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Massachusetts Financial Services Co. MA grew its holdings in Veeva Systems by 64.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,545,451 shares of the technology company’s stock worth $744,084,000 after acquiring an additional 1,392,256 shares during the period. Principal Financial Group Inc. lifted its holdings in Veeva Systems by 138.9% in the 3rd quarter. Principal Financial Group Inc. now owns 2,179,284 shares of the technology company’s stock valued at $457,366,000 after acquiring an additional 1,267,061 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Veeva Systems by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,558,592 shares of the technology company’s stock valued at $536,972,000 after purchasing an additional 1,081,501 shares in the last quarter. FMR LLC grew its stake in shares of Veeva Systems by 25.7% in the 3rd quarter. FMR LLC now owns 2,981,244 shares of the technology company’s stock worth $625,674,000 after purchasing an additional 610,021 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its holdings in shares of Veeva Systems by 761.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 297,771 shares of the technology company’s stock worth $62,493,000 after purchasing an additional 263,214 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Veeva Systems Price Performance
Shares of NYSE:VEEV opened at $216.67 on Friday. The stock has a market capitalization of $35.18 billion, a P/E ratio of 53.50, a P/E/G ratio of 1.91 and a beta of 0.84. The business has a 50-day moving average of $222.68 and a two-hundred day moving average of $209.23. Veeva Systems Inc. has a fifty-two week low of $170.25 and a fifty-two week high of $258.93.
Analysts Set New Price Targets
Read Our Latest Report on VEEV
Insider Activity at Veeva Systems
In other news, SVP Jonathan Faddis sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total value of $390,128.20. Following the sale, the senior vice president now directly owns 8,061 shares of the company’s stock, valued at approximately $1,856,448.30. This trade represents a 17.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Thomas D. Schwenger sold 1,126 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $240.01, for a total value of $270,251.26. Following the transaction, the insider now directly owns 27,013 shares of the company’s stock, valued at $6,483,390.13. This represents a 4.00 % decrease in their position. The disclosure for this sale can be found here. 10.50% of the stock is owned by company insiders.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- How to Calculate Retirement Income: MarketBeat’s Calculator
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Why is the Ex-Dividend Date Significant to Investors?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.